As of 2026-09-15, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is (189.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.22 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is -669.4%.
The range of the Relative Valuation is (171.93) - (203.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 30.5x | 29.9x |
| Forward P/E multiples | 23.9x - 29.4x | 24.8x |
| Fair Price | (171.93) - (203.60) | (189.15) |
| Upside | -617.5% - -712.9% | -669.4% |
| Date | P/E |
| 2026-09-15 | -4.70 |
| 2026-09-14 | -4.80 |
| 2026-09-11 | -4.86 |
| 2026-09-10 | -4.86 |
| 2026-09-09 | -5.01 |
| 2026-09-08 | -4.85 |
| 2026-09-04 | -4.79 |
| 2026-09-03 | -4.79 |
| 2026-09-02 | -4.94 |
| 2026-09-01 | -4.95 |
| 2026-08-31 | -4.87 |
| 2026-08-28 | -4.82 |
| 2026-08-27 | -4.96 |
| 2026-08-26 | -4.91 |
| 2026-08-25 | -4.90 |
| 2026-08-24 | -4.72 |
| 2026-08-21 | -4.78 |
| 2026-08-20 | -4.86 |
| 2026-08-19 | -5.08 |
| 2026-08-18 | -4.97 |
| 2026-08-17 | -4.86 |
| 2026-08-14 | -4.85 |
| 2026-08-13 | -4.84 |
| 2026-08-12 | -4.95 |
| 2026-08-11 | -4.73 |
| 2026-08-10 | -4.71 |
| 2026-08-07 | -4.67 |
| 2026-08-06 | -4.62 |
| 2026-08-05 | -4.59 |
| 2026-08-04 | -4.57 |
| 2026-08-03 | -4.42 |
| 2026-07-31 | -4.34 |
| 2026-07-30 | -4.74 |
| 2026-07-29 | -5.06 |
| 2026-07-28 | -5.20 |
| 2026-07-27 | -5.35 |
| 2026-07-24 | -5.26 |
| 2026-07-23 | -5.25 |
| 2026-07-22 | -5.21 |
| 2026-07-21 | -5.40 |
| 2026-07-20 | -5.79 |
| 2026-07-17 | -5.73 |
| 2026-07-16 | -5.60 |
| 2026-07-15 | -5.77 |
| 2026-07-14 | -5.77 |
| 2026-07-13 | -5.86 |
| 2026-07-10 | -5.96 |
| 2026-07-09 | -6.19 |
| 2026-07-08 | -6.18 |
| 2026-07-07 | -6.36 |